Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karen Rohan Insider Profile
4 Followers
Karen Rohan, President at Aetna Inc, holds 74.90K shares in Aetna Inc (Ticker: AET), holds 0.00 shares in US Bancorp (Ticker: USB), holds 74.69K shares in CVS Health (Ticker: CVS).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-23.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karen Rohan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karen Rohan
Karen Rohan's Trading History
Aetna Inc
Mar 06, 2018
―
Uninformative Buy
1.29M
$15.93M
US Bancorp
―
Director
―
$0.00
CVS Health
Apr 03, 2024
President & CEO, Director
Uninformative Buy
3.60M
$5.20M
Cigna
Jun 26, 2009
Pres. Grp Ins Dntl Vis & Pharm
Uninformative Sell
―
$11.57M
Magellan Health
Mar 06, 2012
―
Uninformative Buy
87.28K
$539.73K
List of latest transactions for each holding click on a transaction to see Karen Rohan's performance on stock
You May Also Like
Karen Rohan insider profile FAQ
What is the percentage of profitable transactions made by Karen Rohan?
The percentage of profitable transactions made by Karen Rohan is 25%.
What is the average return per transaction made by Karen Rohan?
The average return per transaction made by Karen Rohan is -23.40%.
What stocks does Karen Rohan hold?
Karen Rohan holds: AET, USB, CVS, CI, MGLN stocks.
What was Karen Rohan’s latest transaction?
Karen Rohan latest transaction was an Uninformative Buy of $1.29M.
What was Karen Rohan's most profitable transaction?
Karen Rohan’s most profitable transaction was an Informative Buy of CVS stock on May 5, 2023. The return on the trade was 2.20%.
What is Karen Rohan's role in Aetna Inc?
Karen Rohan's role in Aetna Inc is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.